GENEDIS 2026 – Paper 144 – Peripheral Inflammatory Pathway Dysregulation Across the Control–MCI–Alzheimer's Disease Continuum: A Cross-Platform Blood Transcriptomic Analysis

Peripheral immune changes have been reported in Alzheimer’s disease (AD), but their relationship to clinically defined stages remains uncertain. This exploratory secondary analysis compared six MSigDB Hallmark inflammatory pathways in Control, mild cognitive impairment (MCI), and AD whole-blood microarray samples. GSE63060 and GSE63061 contributed 329 and 382 records, respectively, with 238 Control, 189 MCI, and 284 AD records overall; the number of unique participants could not be established. Standardized pathway scores were modeled separately within each batch using ordinary least squares, HC3 standard errors, and an ordinal stage variable (Control=0, MCI=1, AD=2), adjusted for age, sex, and inferred sample origin. False-discovery-rate correction covered six pathways within each batch. Results revealed that four pathways had positive ordinal associations at FDR<0.05 in both batches: inflammatory response (β=0.317/0.251 in GSE63060/GSE63061), TNF-α/NF-κB (0.223/0.214), IL-6/JAK/STAT3 (0.268/0.211), and complement (0.213/0.254). Inflammatory response was higher in MCI than in Control in both batches (β=0.393, FDR=0.0315; β=0.376, FDR=0.0104). No AD–MCI contrast passed the FDR correction within either batch, and neither interferon pathway showed a significant ordinal association within either batch. Complement was sensitive to omission of one origin group in GSE63060. Fixed-effect pooled estimates were kept as supplementary exploratory summaries as possible participant overlap leaves their independence assumption unresolved. Without proving within-person progression, brain-specific neuroinflammation, or diagnostic performance, the results show systemic transcriptional associations at the group level.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-12
DOI
https://doi.org/10.5281/zenodo.24175492
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GENEDIS 2026 – Paper 144 – Peripheral Inflammatory Pathway Dysregulation Across the Control–MCI–Alzheimer's Disease Continuum: A Cross-Platform Blood Transcriptomic Analysis

Marina Nikolidaki
Zenodo (CERN European Organization for Nuclear Research)
Neuroinflammation and Neurodegeneration Mechanisms
article

GENEDIS 2026 – Paper 144 – Peripheral Inflammatory Pathway Dysregulation Across the Control–MCI–Alzheimer's Disease Continuum: A Cross-Platform Blood Transcriptomic Analysis

Marina Nikolidaki
article en

Abstract

Peripheral immune changes have been reported in Alzheimer’s disease (AD), but their relationship to clinically defined stages remains uncertain. This exploratory secondary analysis compared six MSigDB Hallmark inflammatory pathways in Control, mild cognitive impairment (MCI), and AD whole-blood microarray samples. GSE63060 and GSE63061 contributed 329 and 382 records, respectively, with 238 Control, 189 MCI, and 284 AD records overall; the number of unique participants could not be established. Standardized pathway scores were modeled separately within each batch using ordinary least squares, HC3 standard errors, and an ordinal stage variable (Control=0, MCI=1, AD=2), adjusted for age, sex, and inferred sample origin. False-discovery-rate correction covered six pathways within each batch. Results revealed that four pathways had positive ordinal associations at FDR<0.05 in both batches: inflammatory response (β=0.317/0.251 in GSE63060/GSE63061), TNF-α/NF-κB (0.223/0.214), IL-6/JAK/STAT3 (0.268/0.211), and complement (0.213/0.254). Inflammatory response was higher in MCI than in Control in both batches (β=0.393, FDR=0.0315; β=0.376, FDR=0.0104). No AD–MCI contrast passed the FDR correction within either batch, and neither interferon pathway showed a significant ordinal association within either batch. Complement was sensitive to omission of one origin group in GSE63060. Fixed-effect pooled estimates were kept as supplementary exploratory summaries as possible participant overlap leaves their independence assumption unresolved. Without proving within-person progression, brain-specific neuroinflammation, or diagnostic performance, the results show systemic transcriptional associations at the group level.

Zenodo (CERN European Organization for Nuclear Research)
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon